BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News (World)
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014
Actavis (ACT) Launches Generic Version Of Celebrex 12/10/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Daiichi Sankyo, Inc. (4568.t) Launches New Formulation Of LIXIANA 60 mg Tablets (edoxaban) In Japan 12/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia 12/8/2014
Basilea Pharmaceutica (BSLN.SW) Announces Launch Of Antibiotic Zevtera(R) (Ceftobiprole Medocaril) In Germany 12/5/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Actavis (ACT) Launches Generic Version Of Intuniv 12/1/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
European Medicines Agency Recommends Availability Of Laboratoire HRA Pharma's Ellaone Emergency Contraceptive Without Prescription 11/21/2014
France Strikes Deal For Gilead Sciences, Inc. (GILD)'s Hep C Drug Sovaldi 11/21/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Five Percent Of Medicines In Malaysia Are Counterfeit: Pfizer (PFE) 11/11/2014
Oculus Innovative Sciences, Inc. (OCLS) Commercializes Microcyn®-Based Solution And Hydrogel For Treatment Of Mild-To-Moderate Acne In Europe 11/11/2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine 11/11/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
European Medicines Agency Completes Review Of Polymyxin-Based Medicines 10/24/2014
BioSpace’s Favorite FDA Tricks Or Treats 10/24/2014
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014
Admedus Cardiocel® To Be Launched In Canada 10/20/2014
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO 10/20/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
Orexo AB (ORXOF) Submits Application To FDA For Expanded Label Of ZUBSOLV® 10/13/2014
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/9/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/6/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 9/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
Endo International plc (ENDP) Announces Launch Of Authorized Generic Of FORTESTA® Gel 9/8/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014
BioTie Therapies Corp.: Selincro Enters The Market In Germany 8/29/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
Tianyin Pharmaceutical Co, Inc. Receives GMP For Tablets Formulation In Early July 7/7/2014
Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment 7/7/2014
Novartis AG (NVS) Begins Shipment Of Seasonal Influenza Vaccines To US Market For The 2014-2015 Season 7/3/2014
Biogen Idec Canada Release: British Columbia To Reimburse TECFIDERA™, A First-Line Oral Treatment For Multiple Sclerosis 6/25/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Capsules 6/25/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Cepheid (CPHD) Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria 6/16/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014
Both Are Roche (RHHBY)'s Drugs, But Which One Could Save The U.S. $3 Billion? 6/5/2014
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014
ULURU Inc. Announces Shipments Of Altrazeal® To Italy, Spain And Portugal 5/27/2014
TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico 5/16/2014
Actavis (ACT) Launches Generic Version Of Catapres-TTS® 5/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: New Once-Monthly Treatment For Schizophrenia, ABILIFY MAINTENA™ (Aripiprazole For Prolonged Release Injectable Suspension), Now Available In Canada 5/5/2014
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014
Heat On Roche (RHHBY) To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No" 4/23/2014
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/18/2014
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014
Toyama Chemical NDA Approval Of “AVIGAN Tablet 200mg” In Japan For The Anti-influenza Virus Drug 3/24/2014
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014
Essex Medipharma To Distribute Pfizer Inc. (PFE) Glaucoma Eye Drops In China 2/25/2014
Double-Crane Pharmaceutical Co., Ltd. To Distribute Sagent Pharmaceuticals, Inc. Pediatric Drug In China 2/14/2014
Jazz Pharmaceuticals plc (JAZZ) Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 2/12/2014
Mylan Inc. (MYL) Launches First Trastuzumab Biosimilar, Hertraz™, In India 2/3/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch Of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-Acting Antimicrobial Agent Etak 1/22/2014
H. Lundbeck A/S (LUN.CO)'s Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In U.S. Pharmacies 1/21/2014
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/21/2014
Vectura Group plc (VEC.L)'s AirFluSal® Forspiro® Launched In Denmark 1/20/2014
Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children 1/17/2014
Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma 1/17/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Availability Of FAMPYRA® In Ireland To Treat Walking Impairment In Adults With Multiple Sclerosis 1/15/2014
pSivida Corp (PSDV) Reports First Orders For ILUVIEN® Shipped For U.K. National Health Service Hospitals Less Than Seven Weeks After Final National Institute for Clinical Excellence (NICE) Guidance 1/13/2014
UK Lawmakers Criticizes The Government For Spending $702 Million On Roche (RHHBY)'s Tamiflu When Some Researchers Doubt The Medicine's True Efficacy 1/6/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Drug Fycompa In U.S. 1/6/2014
China Halts Imports Of Pfizer Inc. (PFE)'s Diflucan On Paperwork Glitch 12/31/2013
PhotoCure Release: Regulatory Update On Cevira 12/27/2013
Ipsen (IPN.PA) Prepares For The Resupply Of Increlex® In Europe 12/18/2013
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Norway And Sweden 12/18/2013
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Sovaldi™ (Sofosbuvir) For The Treatment Of Chronic Hepatitis C 12/16/2013
AstraZeneca PLC (AZN) And Bristol-Myers Squibb Company (BMY) Pull Diabetes Drug From Germany 12/16/2013
Notices Sent To Ranbaxy Laboratories (RANBAXY.BO), Cipla Ltd. For Overcharging 12/10/2013
Medivir AB (MVRBF)'s Simeprevir Is Now Available For Hepatitis C Patients In Japan, USA And Canada 12/10/2013
EU Agency Starts In-Depth Review Of Ariad Pharmaceuticals, Inc. (ARIA) Leukemia Drug 12/6/2013
Pfizer Inc. (PFE), Hanmi Pharmaceutical, Co., Ltd Brawl Over Design Of Viagra Pill 12/5/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces Additional Regulatory Exclusivity For TREANDA® (Bendamustine HCI) For Injection 11/27/2013
FDA Lifts Constraints On GlaxoSmithKline (GSK) Diabetes Drug Avandia 11/26/2013
Sosei Group Corporation: Once-Daily Ultibro® Inhalation Capsules (QVA149) For COPD Launched In Japan 11/20/2013
Skyepharma PLC (SKYEF)'s Partner Kyorin Launches Flutiform® In Japan 11/19/2013
WuXi PharmaTech Co., Ltd. To Produce New Cancer Drug For Pharmacyclics, Inc. (PCYC) 11/15/2013
NicOx SA (COX.PA) Launches Sjö™ In The U.S. And Partners With The Sjogren's Syndrome Foundation 11/12/2013
Allied Healthcare Group (AHZ:AU) Makes First Sale of Cardiocel ® Into Europe 11/8/2013
National Institute for Clinical Excellence (NICE): Final Draft OK for Lucentis in Rare Eye Condition 10/25/2013
ADImmune Corporation of Taiwan Readies Flu Vaccine for China 10/25/2013
National Institute for Clinical Excellence (NICE) Draft "Yes" for Astellas Pharma Inc. (ALPMY)' Prostate Cancer Drug 10/18/2013
China National Biotech Group's Japanese Encephalitis Vaccine Prequalified by World Health Organization 10/9/2013
Teva Pharmaceutical Industries Limited (TEVA) Sees Obstacles to Copying GlaxoSmithKline (GSK)'s Best-Selling Drug Advair Before 2018 10/9/2013
National Institute for Clinical Excellence (NICE) Backs Roche (RHHBY)'s MabThera in Rare Autoimmune Disease 10/3/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic Zemplar® in the United States 10/1/2013
Lundbeck Inc. (LUN.CO) Launches Selincro® in Denmark 9/30/2013
BioTie Therapies Corp.: Selincro Enters the Market in Italy 9/26/2013
Sun Pharmaceutical Industries Ltd May Get Windfall Gains on Cancer Drug Doxil 9/26/2013
Teva Pharmaceutical Industries Limited (TEVA) Copy to Boost Billionaire-Backed Drugmaker 9/18/2013
National Institute for Clinical Excellence (NICE) Demands More Data for Sanofi (France) (SAN.PA)'s Oral MS Drug 9/18/2013
Eisai Company, Ltd. (ESALY.PK)'s EMEA Ops to Supply Fycompa in U.S. 9/12/2013
GlaxoSmithKline (GSK) Declines as FDA Clears Path for Advair Rivals, $8 Billion in Revenue Threatened 9/10/2013
Orexo AB Provides Update on Reimbursement and Launch Preparations for Zubsolv® 9/5/2013
Government Seeks Evidence on PBS-Listed Cancer Drug Yervoy 8/26/2013
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces the Launch of Divalproex Sodium Extended - Release Tablets, USP 8/22/2013
Pfizer Inc. (PFE) Lung Cancer Drug Xalkori Faces UK Rejection as Too Costly 8/19/2013
Moberg Pharma AB (Formerly known as Moberg Derma) Launches Kerasal® NeuroCream at Walmart and Major U.S. Drugstores 8/12/2013
Teva Pharmaceutical Industries Limited (TEVA) and Perrigo Company (PRGO) Announce the U.S. Launch of Generic Temozolomide 8/12/2013
Moberg Pharma AB (Formerly known as Moberg Derma) Launches Kerasal® NeuroCream at Walmart and Major U.S. Drugstores 8/12/2013
XstalBio Launches CentuRecon™ to Accelerate the Delivery of Biologic Drugs at High Concentration 8/12/2013
UK Cost Agency Turns Down New Roche (RHHBY) Breast Cancer Drug 8/6/2013
Roche (RHHBY) Cuts Cost of Drug to Prevent Blindness in HIV Patients 8/6/2013
Zealand Pharma Informs That Sanofi (France) (SAN.PA) has Provided an Update on the Commercial Roll-Out of Lyxumia® 8/1/2013
Teva Pharmaceutical Industries Limited (TEVA)'s Morning-After Pill Now Available on Store Shelves 8/1/2013
BTG plc (BTG.L) Release: TheraSphere® Recommended by the National Institutes of Health (NIH) for the Treatment of Primary and Secondary Liver Cancer 7/30/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Donepezil Hydrochloride Tablets, 23 mg 7/29/2013
Teva Pharmaceutical Industries Limited (TEVA) Gets Exclusivity on Plan B Contraceptive 7/24/2013
Errors, Misconduct, and an Alleged Cover-Up Attempt Delayed Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY) Medicine 7/15/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Decitabine for Injection 7/12/2013
A Bayer AG (BAY.F) Drug, the European Medicines Agency and Transparency... or the Lack Thereof 7/11/2013
UK Health Watchdog Doesn't Recommend Novartis AG (NVS)'s Afinitor 7/8/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Lamotrigine Extended-Release Tablets 6/26/2013
Eisai Inc. (ESALF.PK) to Pull Epilepsy Drug From Germany 6/26/2013
Actavis (ACT) Launches Generic Viagra® in Europe as Patents Expire 6/24/2013
UK's National Institute for Clinical Excellence (NICE) Rejects Sanofi (France) (SAN.PA) Bowel Cancer Drug 6/21/2013
SkyePharma Inc. (SKYE) Release: flutiform® Launch in Italy Triggers €2 Million Milestone From Marketing Partner Mundipharma AG 6/20/2013
Novo Nordisk A/S (NVO) Drops as New Eli Lilly and Company (LLY) Drug Threatens Victoza 6/18/2013
Takeda Pharmaceutical Co. Ltd. (TKPYY) Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 6/17/2013
Obama Administration Reverses Course on Teva Pharmaceutical Industries Limited (TEVA)'s Plan B Pill 6/11/2013
TiGenix Provides ChondroCelect Update 6/10/2013
FDA Weighs Lifting Safety Restrictions on GlaxoSmithKline (GSK)'s Avandia 6/6/2013
Sacre Bleu! European Agency Rebuffs French Regulator Over Bayer AG (BAY.F) Acne Pill 5/30/2013
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Agent Inovelon® Tablets 100 mg, 200 mg in Japan 5/28/2013
MEDA: Dymista Reimbursed in Sweden 5/23/2013
Immune Response BioPharma Sets Pricing of REMUNE Vaccine in Thailand Between $75 -100 Per Dose 5/20/2013
EMD Millipore Launches OsteoMAX-XF™, a Fully-Defined, Xeno-Free Mesenchymal Stem Cell Osteogenic Differentiation Medium 5/9/2013
Merck & Co., Inc. (MRK), GlaxoSmithKline (GSK) Reduce HPV Vaccine Prices by 95 Pct. in Poorest Regions 5/9/2013
Non Profit to Bayer AG (BAY.F): Withdraw False Vitamin Claims or Else! 5/9/2013
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013